Investing.com – U.S. stocks were higher after the close on Tuesday, as gains in the Technology, Oil & Gas and Utilities sectors led shares higher. At the close in NYSE, the Dow ...

Stifel Nicolaus analyst Alex Thompson CFA maintained a Buy rating on Viridian Therapeutics (VRDN – Research Report) today and set a price target of $41.00. The company’s shares closed last ...

NEW YORK - Protara Therapeutics, Inc. (NASDAQ:TARA), a clinical-stage company focused on developing treatments for cancer and rare diseases, has initiated a public ...

focusing on stocks such as Viridian Therapeutics, Ascendis Pharma, and Spyre Therapeutics. According to TipRanks, Thompson CFA has an average return of -1.2% and a 39.13% success rate on ...

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

After hours: February 7 at 5:43:24 PM EST ...

To enquire about specific property features for 2/29 Meehan Gardens, Narrabundah, contact the agent. What is the size of the property at 2/29 Meehan Gardens, Narrabundah? The property size for 2/ ...